Bridge to Life Ltd. specializes in advanced technologies for organ transplantation and preservation, focusing on enhancing the quality and availability of donor organs. Their flagship products include the Belzer UW® Cold Storage Solution and the Belzer MPS® UW Machine Perfusion Solution, which are designed to optimize the preservation and perfusion of organs. These solutions are critical for organ procurement organizations and transplant centers, ensuring that donor organs remain viable for transplantation. The company is also committed to innovation, as evidenced by their VitaSmart™ Hypothermic Oxygenated Machine Perfusion System, which is currently available in countries that accept the CE Mark and is pending regulatory clearance in others.

In addition to their core preservation technologies, Bridge to Life offers the EasiSlush® Sodium Chloride Solution for sterile slush preparation, which aids in organ preservation during transport. The company emphasizes a partnership approach with the transplant community, aiming to develop simpler and more cost-effective tools that enhance organ delivery and revitalization. By continually exploring new solutions and expanding their product portfolio, Bridge to Life is dedicated to improving outcomes in organ transplantation and ultimately saving more lives.

United States

Bridge to Life was founded with the mission of improving organ transplants through licensing and developing new preservation solutions and technologies to provide the highest quality of service to organ procurement organizations and transplant centers.

Bridge to Life is a leading supplier of preservation solutions globally with a focus on innovation in organ preservation and machine perfusion. Through a strong focus on collaboration with surgeons and transplant professionals, we continue to explore emerging science and preservation technologies.

Bridge to Life Ltd.

Company Details